Swiss medical technology company Ypsomed said on Friday it will establish its first manufacturing facility in the United States with an initial $200 million investment in the town of Holly Springs, North Carolina.
Ypsomed, a maker of self-injection systems, said it plans to create about 100 new jobs and wants to roughly double that number in the coming years as demand rises. The plant is due to begin supplying the U.S. market from the end of 2027.
Sign up here… [627 chars]
Source: Reuters | Published: 2025-10-10T05:57:24Z
Credit: Reuters
